← Evidence map

ArticleCurrent oncology (Toronto, Ont.)2024

Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response.

Teiji Kuzuya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39451767